A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis

Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody—Associated Vasculitis

(2013) Kirsten de Groot   ANNALS OF INTERNAL MEDICINE

Microvascular Responses to Cardiovascular Risk Factors

(2010) D. NEIL GRANGER et al.   MICROCIRCULATION

Epidemiological features of Wegener's granulomatosis and microscopic polyangiitis: two diseases or one ‘anti-neutrophil cytoplasm antibodies-associated vasculitis’ entity?

(2009) ALFRED D. MAHR   APMIS

Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: A matched-pair cohort study

(2009) Matthew D. Morgan et al.   ARTHRITIS AND RHEUMATISM

Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis

(2009) Mikkel Faurschou et al.   ARTHRITIS AND RHEUMATISM

Glucocorticoid-Induced Hyperglycemia

(2009) John Clore et al.   Endocrine Practice

The Scope of Coronary Heart Disease in Patients With Chronic Kidney Disease

(2009) Fadi G. Hage et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies

(2009) C. Meune et al.   RHEUMATOLOGY

EULAR recommendations for the management of primary small and medium vessel vasculitis

(2008) C Mukhtyar et al.   ANNALS OF THE RHEUMATIC DISEASES

General Cardiovascular Risk Profile for Use in Primary Care

(2008) Ralph B. D’Agostino et al.   CIRCULATION